TABLE 4.
Protein | MAb binding (RU)a
|
|||||
---|---|---|---|---|---|---|
10A6 | 1D11 | 4H7 | 1E12 | 4F6 | Control MAbb | |
Ib | 342 | 639 | 285 | 234 | 299 | 87 |
Ib 107-665 | 0 | 664 | −27 | −29 | 532 | 10 |
Ib 224-665 | −8 | 794 | −37 | −27 | 351 | 10 |
Ib 358-665 | −3 | 563 | −6 | −2 | 632 | 5 |
Ib 466-665 | −12 | 687 | −34 | −29 | 454 | 16 |
Ib 1-66 | 244 | 18 | 206 | 232 | −43 | 36 |
Ib 1-323 | 242 | −27 | 202 | 281 | 21 | −13 |
Ib 1-466 | 274 | −1 | 191 | 157 | 4 | 22 |
Ib 1-631 | 142 | −8 | 117 | 121 | 5 | 3 |
Ib 1-655 | 181 | 144 | 133 | 147 | 131 | 7 |
HBS-EPc | −46 | −36 | −47 | −36 | 22 | 6 |
MAbs captured by the RAM Fc surface varied between 1,130 and 1,730 RU. Values represent the RU due to MAb binding of the designated recombinant Ib or truncated variant. Results were considered positive if the RU were 2.5-fold or greater than that for the control MAb.
Control MAb recognized C. botulinum neurotoxin A, but not Ib, as determined by an ELISA.
HBS-EP, negative control containing only buffer and surfactant.